Mersana Therapeutics, Inc. (MRSN)
USD 1.69
(-16.75%)
USD 1.69
(-16.75%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 36.85 Million | 26.58 Million | 43 Thousand | 828 Thousand | 42.12 Million | 10.59 Million |
| Cost of Revenue | 148.26 Million | 927 Thousand | 132.01 Million | 67.03 Million | 55.04 Million | 59.91 Million |
| Gross Profit | -111.41 Million | 25.65 Million | -131.97 Million | -66.2 Million | -12.91 Million | -49.32 Million |
| Operating Expenses | 207.81 Million | 230.34 Million | 168.9 Million | 88.93 Million | 72.32 Million | 76.24 Million |
| Selling, General and Administrative Expenses | 59.54 Million | 56.96 Million | 36.88 Million | 21.9 Million | 17.28 Million | 16.33 Million |
| Research and Development Expenses | 148.26 Million | 173.38 Million | 132.01 Million | 67.03 Million | 55.04 Million | 59.91 Million |
| Other Expenses | - | -445 Thousand | -1.2 Million | - | - | 1.39 Million |
| Cost and Expenses | 207.81 Million | 230.34 Million | 168.9 Million | 88.93 Million | 72.32 Million | 76.24 Million |
| Operating Income | -170.95 Million | -204.69 Million | -169.71 Million | -87.68 Million | -29.21 Million | -65.65 Million |
| Interest Expense | 4.07 Million | 3.32 Million | 1.26 Million | 359 Thousand | 234 Thousand | - |
| Income Tax Expense | - | 3.32 Million | -855 Thousand | 359 Thousand | -1.01 Million | 1.39 Million |
| Earnings before Tax | -171.67 Million | -204.21 Million | -170.06 Million | -88.04 Million | -28.2 Million | -64.25 Million |
| Net Income | -171.67 Million | -207.54 Million | -169.2 Million | -88.4 Million | -27.19 Million | -64.25 Million |
| Earnings Per Share Basic | -1.48 | -2.22 | -2.40 | -1.44 | -0.63 | -2.79 |
| Earnings Per Share Diluted | -1.48 | -2.22 | -2.40 | -1.44 | -0.63 | -2.79 |
| Weighted Average Shares Outstanding | 116.11 Million | 93.65 Million | 70.58 Million | 61.48 Million | 43.39 Million | 23.03 Million |
| Weighted Average Shares Outstanding (Diluted) | 116.11 Million | 93.65 Million | 70.58 Million | 61.48 Million | 43.49 Million | 23.03 Million |
| Gross Margin | -3.02 | 0.97 | -3069.07 | -79.96 | -0.31 | -4.66 |
| EBIT Margin | -4.51 | -7.67 | -3926.93 | -104.68 | -0.66 | -6.20 |
| Profit Margin | -4.66 | -7.81 | -3935.00 | -106.77 | -0.65 | -6.07 |
| EBITDA | -166.08 Million | -199.95 Million | -167.93 Million | -86.67 Million | -26.72 Million | -63 Million |
| Earnings Before Tax Margin | -4.64 | -7.70 | -3946.81 | -105.90 | -0.69 | -6.20 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 2.29 Million | 9.24 Million | 36.85 Million | 10.7 Million | 7.69 Million | 10.65 Million |
| Cost of Revenue | 403 Thousand | 423 Thousand | 1.51 Million | 447 Thousand | 427 Thousand | 324 Thousand |
| Gross Profit | 1.89 Million | 8.82 Million | 35.33 Million | 10.25 Million | 7.27 Million | 10.33 Million |
| Operating Expenses | 27.74 Million | 29.82 Million | 206.29 Million | 31.18 Million | 51.63 Million | 67.15 Million |
| Selling, General and Administrative Expenses | 10.5 Million | 11.13 Million | - | 9.68 Million | 12.89 Million | 18.18 Million |
| Research and Development Expenses | 17.24 Million | 18.68 Million | - | 21.49 Million | 30.53 Million | 48.96 Million |
| Other Expenses | - | - | 8.71 Million | -1.69 Million | 8.21 Million | 2.19 Million |
| Cost and Expenses | 27.74 Million | 30.24 Million | 207.81 Million | 31.62 Million | 51.63 Million | 67.15 Million |
| Operating Income | -24.26 Million | -21 Million | -170.95 Million | -20.92 Million | -41.65 Million | -54.3 Million |
| Interest Expense | -983 Thousand | 1 Million | 4.07 Million | 1.04 Million | -1.01 Million | 1.02 Million |
| Income Tax Expense | 784 Thousand | 379.72 Thousand | 1.34 Million | 5.69 Million | -6.35 Million | -324 Thousand |
| Earnings before Tax | -24.26 Million | -19.3 Million | -171.67 Million | -19.54 Million | -41.65 Million | -54.3 Million |
| Net Income | -24.26 Million | -19.3 Million | -171.67 Million | -19.54 Million | -41.65 Million | -54.3 Million |
| Earnings Per Share Basic | -0.20 | -0.16 | - | -0.16 | -0.35 | -0.47 |
| Earnings Per Share Diluted | -0.20 | -0.16 | - | -0.16 | -0.35 | -0.47 |
| Weighted Average Shares Outstanding | 121.42 Million | 121.42 Million | 116.11 Million | 120.61 Million | 120.52 Million | 115.6 Million |
| Weighted Average Shares Outstanding (Diluted) | 121.42 Million | 121.42 Million | 116.11 Million | 120.61 Million | 120.52 Million | 115.6 Million |
| Gross Margin | 0.82 | 0.95 | 0.96 | 0.96 | 0.94 | 0.97 |
| EBIT Margin | -10.58 | -2.23 | - | -1.91 | -5.41 | -5.30 |
| Profit Margin | -10.58 | -2.09 | -4.66 | -1.83 | -5.41 | -5.10 |
| EBITDA | -24.26 Million | -20.57 Million | - | -20.48 Million | -41.65 Million | -56.5 Million |
| Earnings Before Tax Margin | -10.58 | -2.27 | -4.64 | -1.96 | -5.41 | -5.10 |
2330
NNAX
GV
0433
KK
LES